Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79238 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Cefepime Dihydrochloride Monohydrate
CAS:Fórmula:C19H24N6O5S2(HCl)H2OPeso molecular:480.56 : 2(36.46) : 18.02Tolvaptan-d7
CAS:Produto Controlado<p>Applications Labelled Tolvaptan. It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Paterna, S., et al.: Eur. J. Heart Fail, 2, 305 (2000), Udelson, J., et al.: Circulation, 104, 2417 (2001), Goldsmith, S., et al.: J. Am. Coll Cardiol., 46, 1785 (2005), Schrier, R., et al.: N. Engl. J. Med., 355, 2099 (2006),<br></p>Fórmula:C26H18D7ClN2O3Cor e Forma:NeatPeso molecular:455.98Solifenacin EP Impurity F (Succinate Salt)
CAS:Fórmula:C23H26N2O2C4H6O4Peso molecular:362.47 : 118.092-(3-Cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic Acid Ethyl Ester
CAS:<p>Applications 2-(3-Cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic Acid Ethyl Ester, can be used for the synthesis of Febuxostat (F229000), an antipodagrics.<br>References Zheng, F., et al.: Zhongguo Yiyao Gongye Zazhi, 40, 726 (2009);<br></p>Fórmula:C14H12N2O3SCor e Forma:NeatPeso molecular:288.32(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid
CAS:Fórmula:C21H17ClN2O5Peso molecular:412.838-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-benzo[f]imidazo[1,5-a][1,4]diazepine
CAS:Fórmula:C18H15ClFN3Peso molecular:327.8Bimatoprost Acid
CAS:Produto Controlado<p>Applications Bimatoprost Acid is an impurity of the antiglaucoma agent Bimatoprost (B386820).Bimatoprost Acid is a metabolically stable analog of PGF2α (P838625) and is a potent agonist for the FP receptor.<br>References Balapure, A.K. et al.: Biochem. Pharmacol., 38, 2375 (1989); Hellberg, M.R. et al.: J. Ocular Pharmacol. Ther., 19, 97 (2003); Krishna, P.M. et al.: J. Pharm. res., 4, 2381 (2011);<br></p>Fórmula:C23H32O5Cor e Forma:White To Off-WhitePeso molecular:388.503-Descyano-3-((hydroxyimino)methyl) Febuxostat
CAS:Produto ControladoFórmula:C16H18N2O4SCor e Forma:NeatPeso molecular:334.39Pentoxifylline-d6
CAS:Produto Controlado<p>Applications A labelled metabolite of Pentifylline. Methylxanthine derivative that improves blood flow by decreasing blood viscosity. Phosphodiesterase inhibitor. Inhibits the synthesis of tumor necrosis factor α (TNF-α).<br>References Ward, A., et al.: Drugs, 34, 50 (1987), Samlaska, C.P., et al.: J. Am. Acad. Dermatol., 30, 603 (1994), Poulakis, et al.: Respir. Med., 93, 52 (1999), Reuter, et al.: Am J. Physiol., 277, 854 (1999),<br></p>Fórmula:C132H6H12N4O3Cor e Forma:NeatPeso molecular:284.345,6-trans Travoprost
CAS:<p>Applications An 5,6-trans isomeric impurity of the selective FP prostaglandin receptor agonist Travoprost (T715600).<br></p>Fórmula:C26H35F3O6Cor e Forma:NeatPeso molecular:500.55Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
CAS:Fórmula:C14H13NO4SCor e Forma:NeatPeso molecular:291.32Apixaban Dimer
CAS:Produto Controlado<p>Applications Apixaban Dimer is an impurity compound of Apixaban (A726700). Apixaban is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. It is a potential new oral coagulant that may be useful in the prevention of venous thromboembolism in total hip, knee replacement orthopedic surgery and stroke in treatment of patient with venous thromboembolic disorder or with atrial fibrillation.<br>References Luettgen, J. M. et al.: J. Enz. Inhib. Med. Chem., 26, 514 (2011); Glanis, T. et al.: J. Thromb. Thrombol., 31, 310 (2011); barrett, Y.C. et al.: Thromb. Haemos., 105, 181 (2011);<br></p>Fórmula:C40H34N10O6Cor e Forma:NeatPeso molecular:750.78Desisobutyl Febuxostat
CAS:Produto ControladoFórmula:C12H8N2O3SCor e Forma:Light Yellow SolidPeso molecular:260.27Ro 25-6981 Maleate
CAS:<p>Ro 25-6981 Maleate is an NMDA receptor antagonist used in the study of neurological disorders such as Parkinson's and epilepsy.</p>Fórmula:C26H33NO6Pureza:99.42%Cor e Forma:SolidPeso molecular:455.54Argatroban
CAS:<p>Argatroban (MCI-9038), a specific thrombin inhibitor, which is a non-heparin anticoagulant, prevents the formation of thrombi.</p>Fórmula:C23H36N6O5SPureza:99.77% - >99.99%Cor e Forma:White To Off-White Crystalline SolidPeso molecular:508.63Selexipag
CAS:Produto Controlado<p>Applications Selexipag is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans.<br>References Kuwano, K., et al.: J. Pharm. Exp. Ther., 322, 1181 (2007);<br></p>Fórmula:C26H32N4O4SCor e Forma:Light YellowPeso molecular:496.62
![(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FST-EA%2Fthumb-webp%2FEA-CP-T31012.webp&w=3840&q=75)
![8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-benzo[f]imidazo[1,5-a][1,4]diazepine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FST-EA%2Fthumb-webp%2FEA-CP-M85028.webp&w=3840&q=75)
